GENE ONLINE|News &
Opinion
Blog

2026-02-04|

Dole plc to Release 2025 Financial Results on February 24, 2026, and Transition to U.S. Domestic Issuer Forms

by GOAI
Share To

Dole plc has announced the scheduled release of its financial results for the fourth quarter and full year of 2025. The company plans to disclose these results on Tuesday, February 24, 2026. In addition to this announcement, Dole plc revealed its decision to voluntarily transition to filing reports using U.S. domestic issuer forms starting in 2026.

The company stated that this voluntary election aligns with its ongoing efforts to streamline reporting processes and comply with regulatory standards applicable to U.S.-listed companies. Dole plc has not provided further details regarding the anticipated financial results or specific implications of the change in filing status. The upcoming release will provide stakeholders with insights into the company’s performance during the previous fiscal year and any potential updates on operational strategies moving forward.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: February 4, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
FTI Consulting Expands Middle East Healthcare Advisory with Two Senior Hires
2026-02-09
Diego De Giorgi Appointed Head of EMEA at Apollo Global Management
2026-02-09
Researchers at Nanjing University Induce Nonlinear Hall Effect in MoS2 Thin Flakes Using Electrochemical Intercalation Technique
2026-02-09
UC Irvine Scientists Develop Enzyme for Faster and More Accurate RNA Synthesis
2026-02-09
Machine Learning Method Developed by Chinese Researchers Analyzes Secondary Structures of Nucleic Acid Aptamers
2026-02-09
Study Finds Elevated Mortality Rates Among Youth With Autism, Intellectual Disability, and Cerebral Palsy
2026-02-09
Study Develops Method Using Supply Chain Networks to Measure Speed of Energy Transition in Industries
2026-02-09
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-23
DCAT Week
New York, USA
Scroll to Top